Related Experiment Videos
'Designer drugs'. A problem in clinical toxicology
1San Francisco Regional Poison Control Center, San Francisco General Hospital, University of California.
Medical Toxicology and Adverse Drug Experience
|January 1, 1988
Summary
Designer drugs, often misrepresented, are typically pharmaceutical research derivatives used recreationally. These substances, including phenylethylamines and synthetic opioids, pose significant health risks and can lead to fatal overdoses.
Area of Science:
- Pharmacology
- Toxicology
- Medicinal Chemistry
Background:
- Designer drugs are recreational substances derived from approved drugs to bypass legal restrictions.
- The term is often imprecise, with most designer drugs originating from legitimate pharmaceutical research rather than novel creations.
- These compounds represent evolving mind-altering chemicals with diverse pharmacological properties.
Purpose of the Study:
- To review the classes and pharmacological effects of designer drugs.
- To highlight the risks associated with designer drug use, including overdose and long-term health consequences.
- To discuss the clinical presentation and management of designer drug intoxication.
Main Methods:
- Review of scientific literature on designer drugs.
- Analysis of pharmacological properties of phenylethylamines, synthetic opioids, and arylhexylamines.
- Discussion of clinical toxicology and treatment strategies for designer drug overdose.
Main Results:
- Phenylethylamines (e.g., amphetamine, MDMA) can cause sympathomimetic and psychoactive effects, with overdose symptoms similar to amphetamine, potentially leading to death from cardiac or neurological complications.
- Synthetic opioid derivatives (e.g., fentanyl analogues) are highly potent and associated with numerous overdose deaths. Accidental synthesis of MPTP led to Parkinsonism.
- Arylhexylamines, such as phencyclidine (PCP), exhibit broad and complex psychoactive effects.
Conclusions:
- Designer drugs encompass diverse chemical classes with significant potential for abuse and toxicity.
- Understanding the pharmacology and toxicology of these substances is crucial for clinical management and harm reduction.
- Despite their varied structures, designer drugs share risks of overdose, severe adverse effects, and potential for fatal outcomes.